Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori
Research output: Contribution to journal › Article › peer-review
Standard Standard
In: Cell Host and Microbe, Vol. 19, No. 1, 13.01.2016, p. 55-66.
Research output: Contribution to journal › Article › peer-review
HarvardHarvard
APA
CBE
MLA
VancouverVancouver
Author
RIS
TY - JOUR
T1 - Structural Insights into Polymorphic ABO Glycan Binding by Helicobacter pylori
AU - Moonens, K.
AU - Gideonsson, P.
AU - Subedi, S.
AU - Bugaytsova, J.
AU - Romaõ, E.
AU - Mendez, M.
AU - Nordén, J.
AU - Fallah, M.
AU - Rakhimova, L.
AU - Shevtsova, A.
AU - Lahmann, Martina
AU - Castaldo, G.
AU - Brännström, K.
AU - Coppens, F.
AU - Lo, A.W.
AU - Ny, T.
AU - Solnick, J.V.
AU - Vandenbussche, G.
AU - Oscarson, S.
AU - Hammarström, L.
AU - Arnqvist, A.
AU - Berg, D.E.
AU - Muyldermans, S.
AU - Borén, T.
AU - Remaut, H.
PY - 2016/1/13
Y1 - 2016/1/13
N2 - The Helicobacter pylori adhesin BabA binds mucosal ABO/Leb blood group (bg) carbohydrates. BabA facilitates bacterial attachment to gastric surfaces, increasing strain virulence and forming a recognized risk factor for peptic ulcers and gastric cancer. High sequence variation causes BabA functional diversity, but the underlying structural-molecular determinants are unknown. We generated X-ray structures of representative BabA isoforms that reveal a polymorphic, three-pronged Leb binding site. Two diversity loops, DL1 and DL2, provide adaptive control to binding affinity, notably ABO versus O bg preference. H. pylori strains can switch bg preference with single DL1 amino acid substitutions, and can coexpress functionally divergent BabA isoforms. The anchor point for receptor binding is the embrace of an ABO fucose residue by a disulfide-clasped loop, which is inactivated by reduction. Treatment with the redoxactive pharmaceutic N-acetylcysteine lowers gastric mucosal neutrophil infiltration in H. pylori-infected Leb-expressing mice, providing perspectives on possible H. pylori eradication therapies.
AB - The Helicobacter pylori adhesin BabA binds mucosal ABO/Leb blood group (bg) carbohydrates. BabA facilitates bacterial attachment to gastric surfaces, increasing strain virulence and forming a recognized risk factor for peptic ulcers and gastric cancer. High sequence variation causes BabA functional diversity, but the underlying structural-molecular determinants are unknown. We generated X-ray structures of representative BabA isoforms that reveal a polymorphic, three-pronged Leb binding site. Two diversity loops, DL1 and DL2, provide adaptive control to binding affinity, notably ABO versus O bg preference. H. pylori strains can switch bg preference with single DL1 amino acid substitutions, and can coexpress functionally divergent BabA isoforms. The anchor point for receptor binding is the embrace of an ABO fucose residue by a disulfide-clasped loop, which is inactivated by reduction. Treatment with the redoxactive pharmaceutic N-acetylcysteine lowers gastric mucosal neutrophil infiltration in H. pylori-infected Leb-expressing mice, providing perspectives on possible H. pylori eradication therapies.
U2 - 10.1016/j.chom.2015.12.004
DO - 10.1016/j.chom.2015.12.004
M3 - Article
VL - 19
SP - 55
EP - 66
JO - Cell Host and Microbe
JF - Cell Host and Microbe
SN - 1931-3128
IS - 1
ER -